Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012


#155492

139pages

GlobalData

$ 2500

In Stock


Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012" provides data on the Kidney Cancer (Renal Cell Cancer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Cancer (Renal Cell Cancer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kidney Cancer (Renal Cell Cancer). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 5
List of Figures 7
Introduction 8
Kidney Cancer (Renal Cell Cancer) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Kidney Cancer (Renal Cell Cancer) 25
Subjects Recruited Over a Period of Time 35
Prominent Sponsors 36
Top Companies Participating in Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials 38
Prominent Drug Comparison 40
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Bristol-Myers Squibb Company 51
Clinical Trial Overview of Bristol-Myers Squibb Company 51
Eli Lilly and Company 52
Clinical Trial Overview of Eli Lilly and Company 52
Amgen Inc. 53
Clinical Trial Overview of Amgen Inc. 53
AVEO Pharmaceuticals, Inc. 54
Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 54
Argos Therapeutics, Inc. 55
Clinical Trial Overview of Argos Therapeutics, Inc. 55
Pierre Fabre Medicament 56
Clinical Trial Overview of Pierre Fabre Medicament 56
Abbott Laboratories 57
Clinical Trial Overview of Abbott Laboratories 57
AstraZeneca PLC 58
Clinical Trial Overview of AstraZeneca PLC 58
Agenus, Inc. 59
Clinical Trial Overview of Agenus, Inc. 59
Genentech, Inc. 60
Clinical Trial Overview of Genentech, Inc. 60
Seattle Genetics, Inc. 61
Clinical Trial Overview of Seattle Genetics, Inc. 61
Hoffmann-La Roche Inc. 62
Clinical Trial Overview of Hoffmann-La Roche Inc. 62
F. Hoffmann-La Roche Ltd. 63
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63
Oxford BioMedica plc 64
Clinical Trial Overview of Oxford BioMedica plc 64
Celgene Corporation 65
Clinical Trial Overview of Celgene Corporation 65
Novartis Pharmaceuticals Corporation 66
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 66
Clinical Trial Overview of Top Universities / Institutes / Hospitals 67
Memorial Sloan Kettering Cancer Center 67
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67
The University of Texas M. D. Anderson Cancer Center 71
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 71
UCLA's Jonsson Comprehensive Cancer Center 74
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 74
Case Comprehensive Cancer Center 76
Clinical Trial Overview of Case Comprehensive Cancer Center 76
The University of Chicago 77
Clinical Trial Overview of The University of Chicago 77
Roswell Park Cancer Institute 78
Clinical Trial Overview of Roswell Park Cancer Institute 78
Beth Israel Deaconess Medical Center 79
Clinical Trial Overview of Beth Israel Deaconess Medical Center 79
Radboud University 80
Clinical Trial Overview of Radboud University 80
Barbara Ann Karmanos Cancer Institute 81
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 81
Wake Forest University 82
Clinical Trial Overview of Wake Forest University 82
Fred Hutchinson Cancer Research Center 83
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 83
Sarah Cannon Research Institute 84
Clinical Trial Overview of Sarah Cannon Research Institute 84
Mayo Clinic 85
Clinical Trial Overview of Mayo Clinic 85
Masonic Cancer Center 86
Clinical Trial Overview of Masonic Cancer Center 86
University Health Network 87
Clinical Trial Overview of University Health Network 87
Dana-Farber Cancer Institute 88
Clinical Trial Overview of Dana-Farber Cancer Institute 88
Fox Chase Cancer Center 89
Clinical Trial Overview of Fox Chase Cancer Center 89
Duke University 90
Clinical Trial Overview of Duke University 90
The Methodist Hospital System 91
Clinical Trial Overview of The Methodist Hospital System 91
University of California, San Francisco 92
Clinical Trial Overview of University of California, San Francisco 92
Five Key Clinical Profiles 93

Appendix 136
Abbreviations 136
Definitions 136
Research Methodology 137
Secondary Research 137
About GlobalData 138
Contact Us 138
Disclaimer 138
Source 139

Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 35
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 39
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 40
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 41
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 45
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 47
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 49
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 51
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 52
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 53
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012* 54
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Argos Therapeutics, Inc., 2012* 55
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierre Fabre Medicament, 2012* 56
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 57
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 58
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Agenus, Inc., 2012* 59
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 60
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012* 61
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012* 62
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 63
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxford BioMedica plc, 2012* 64
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 65
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2012* 66
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 67
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 71
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 74
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 76
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012* 77
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 78
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 79
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 80
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 81
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 82
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 83
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 84
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 85
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 86
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 87
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 88
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012* 89
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 90
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Methodist Hospital System, 2012* 91
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 92
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 35
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 36
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 38
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 40
GlobalData Methodology 137